Immunovant, Inc. IMVT Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s share-based payment award options outstanding - number?
- Immunovant, Inc. (IMVT) reported share-based payment award options outstanding - number of 10.6M in Q4 2025.
- How has Immunovant, Inc.'s share-based payment award options outstanding - number changed year-over-year?
- Immunovant, Inc.'s share-based payment award options outstanding - number decreased by 19.8% year-over-year, from 13.2M to 10.6M.
- What is the long-term trend for Immunovant, Inc.'s share-based payment award options outstanding - number?
- Over 4 years (2021 to 2025), Immunovant, Inc.'s share-based payment award options outstanding - number has grown at a 12.9% compound annual growth rate (CAGR), from 8M to 13M.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.